Keith A. Goldan's Net Worth
$1.37 Million
Who is Keith A. Goldan?
Keith A. Goldan has an estimated net worth of $1.37 Million. This is based on reported shares across multiple companies, which include NUPATHE INC., Fibrocell Science, Inc., OptiNose, Inc., and Syndax Pharmaceuticals Inc.
SEC CIK
Keith A. Goldan's CIK is 0001495411
Past Insider Trading and Trends
2020 was Keith A. Goldan's most active year for acquiring shares with 5 total transactions. Keith A. Goldan's most active month to acquire stocks was the month of February. 2021 was Keith A. Goldan's most active year for disposing of shares, totalling 4 transactions. Keith A. Goldan's most active month to dispose stocks was the month of January. 2022 saw Keith A. Goldan paying a total of $3,588,000.00 for 441,215 shares, this is the most they've acquired in one year. In 2014 Keith A. Goldan cashed out on 265,770 shares for a total of $1,615,804.32, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NUPATHE INC. No price found
CFO and SVP
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -166.07K |
$6.80 | -$1,129,248.80 |
0
|
Feb 21
| |||
Form 4
| +304.39% | 125K |
—
|
—
| 166.07K |
Jan 17
| |||
Form 4
| +756.97% | 36.27K |
—
|
—
| 41.07K |
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
∞
| 4.79K |
$8.00 |
—
| 4.79K |
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fibrocell Science, Inc. No price found
SVP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 2K |
$6.33 | $12,660.00 | 2K |
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OptiNose, Inc. (OPTN) Snapshot price: $1.265
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.15% | -4.62K |
$2.11 | -$9,741.87 | 141.73K |
Mar 16
| |||
Form 4
| +63.31% | 56.73K |
—
|
—
| 146.34K |
Jan 11
| |||
Form 4
| -0.64% | -580.00 |
$1.64 | -$951.20 | 89.61K |
Dec 16
| |||
Form 4
| -0.64% | -578.00 |
$2.79 | -$1,612.04 | 90.19K |
Sep 16
| |||
Form 4
| -0.63% | -576.00 |
$3.73 | -$2,148.48 | 90.77K |
Jun 17
| |||
Form 4
| -2.46% | -2.30K |
$3.92 | -$9,031.68 | 91.35K |
Mar 15
| |||
Form 4/A
| +452.11% | 30.57K |
—
|
—
| 37.33K |
Mar 6
| |||
Form 4
| +546.95% | 53.33K |
—
|
—
| 63.08K |
Mar 4
| |||
Form 4
| +34.48% | 2.5K |
$3.90 | $9,742.50 | 9.75K |
Sep 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
| +30.11% | 941 |
$5.64 | $5,307.24 | 4.07K |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $22.65
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,854.83% | 48.74K |
$17.72 | $36,227.30 | 51.37K |
Jul 31 - Feb 7
| |||
Form 4
| -18.00% | -577.00 |
$22.31 | -$12,872.87 | 2.63K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
∞
| 3.21K |
—
|
—
| 3.21K |
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||